Movement Alert|SENSETIME-W Rises 3.7% in Regular Trading, Medical Subsidiary Completes Over $100M B-Round Financing as WAIC Catalysts Continue

Market Focus07-28

On July 28, SENSETIME-W rose 3.7% in regular trading, trading at HKD 1.4/share, with turnover of HKD 471 million.

On the news front, SenseTime Medical recently completed a B-round financing exceeding USD 100 million, becoming the first medical world model company with a valuation surpassing RMB 10 billion. Investors include Lianchuang Capital, China Electronics Health Medical Big Data fund, Lianmei Group, and multiple institutional investors including large insurers and brokerage direct investment arms.

Additionally, multiple achievements unveiled at WAIC continue to catalyze market sentiment. The company formally launched its flagship multimodal base model SenseNova U1 Pro, positioned as an industry-first delivery-grade native multimodal agent foundation for long-horizon tasks. Its MaaS model-as-a-service business has demonstrated explosive growth, with Q1 single-quarter revenue reaching 40% of full-year levels. Goldman Sachs has predicted the company will achieve positive EBITDA, while GF Securities raised its target price, projecting revenue growth above 25% over the next three years.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment